Amplicon sequencing demonstrates comparable follicular mycobiomes in patients with hidradenitis suppurativa compared with healthy controls

H. C. Ring; J. Thorsen; K. Fuursted; T. Bjarnsholt; L. Bay; A. Egeberg; A. C. Ingham; H. Vedel Nielsen; J. W. Frew; D. M.L. Saunte; S. F. Thomsen; G. B. Jemec

doi:10.1111/jdv.18075

Amplicon sequencing demonstrates comparable follicular mycobiomes in patients with hidradenitis suppurativa compared with healthy controls

H. C. Ring^*, J. Thorsen, K. Fuursted, T. Bjarnsholt, L. Bay, A. Egeberg, A. C. Ingham, H. Vedel Nielsen, J. W. Frew, D. M.L. Saunte, S. F. Thomsen, G. B. Jemec

^*Corresponding author af dette arbejde

6 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Journal of the European Academy of Dermatology and Venereology
Vol/bind	36
Udgave nummer	7
Sider (fra-til)	e580-e583
ISSN	0926-9959
DOI	https://doi.org/10.1111/jdv.18075
Status	Udgivet - jul. 2022

Adgang til dokumentet

10.1111/jdv.18075

Andre filer og links

Link to publication in Scopus

Citationsformater

Ring, H. C., Thorsen, J., Fuursted, K., Bjarnsholt, T., Bay, L., Egeberg, A., Ingham, A. C., Vedel Nielsen, H., Frew, J. W., Saunte, D. M. L., Thomsen, S. F., & Jemec, G. B. (2022). Amplicon sequencing demonstrates comparable follicular mycobiomes in patients with hidradenitis suppurativa compared with healthy controls. Journal of the European Academy of Dermatology and Venereology, 36(7), e580-e583. https://doi.org/10.1111/jdv.18075

Ring, HC , Thorsen, J, Fuursted, K, Bjarnsholt, T, Bay, L, Egeberg, A, Ingham, AC, Vedel Nielsen, H, Frew, JW, Saunte, DML , Thomsen, SF & Jemec, GB 2022, 'Amplicon sequencing demonstrates comparable follicular mycobiomes in patients with hidradenitis suppurativa compared with healthy controls', Journal of the European Academy of Dermatology and Venereology, bind 36, nr. 7, s. e580-e583. https://doi.org/10.1111/jdv.18075

@article{19c9429bd7b14771a5c5fee1e9acabb9,

title = "Amplicon sequencing demonstrates comparable follicular mycobiomes in patients with hidradenitis suppurativa compared with healthy controls",

keywords = "Hidradenitis Suppurativa/genetics, Humans, Mycobiome",

author = "Ring, {H. C.} and J. Thorsen and K. Fuursted and T. Bjarnsholt and L. Bay and A. Egeberg and Ingham, {A. C.} and {Vedel Nielsen}, H. and Frew, {J. W.} and Saunte, {D. M.L.} and Thomsen, {S. F.} and Jemec, {G. B.}",

note = "Funding Information: Dr. Ring has received research funding from the Kgl Hofbundtmager Aage Bang Foundation and honoraria as speaker from Leo Pharma. Dr. Thorsen. None. Ms. Bay None. Prof. TB none. Dr. KF None. Ms. AI None. Dr. Frew has conducted advisory work for Janssen, Boehringer‐Ingelheim, Pfizer, Kyowa Kirin, LEO Pharma, Regeneron, Chemocentryx, Abbvie and UCB, participated in trials for Pfizer, UCB, Boehringer‐Ingelheim, Eli Lilly, CSL, Janssen and received research support from Ortho Dermatologics and Sun Pharma. Mr. HV None. Dr. Thomsen has been a speaker and/or served on advisory boards for AbbVie, Almirall, Eli Lilly, Janssen, LEO Pharma, Novartis, Pfizer, Sanofi and UCB, and has received research support from AbbVie, Janssen, LEO Pharma, Novartis, Sanofi and UCB. Dr. Egeberg has received research funding from Pfizer, Eli Lilly, Novartis, Bristol‐Myers Squibb, AbbVie, Janssen Pharmaceuticals, the Danish National Psoriasis Foundation, the Simon Spies Foundation, and the Kgl Hofbundtmager Aage Bang Foundation, and honoraria as consultant and/or speaker from AbbVie, Almirall, Leo Pharma, Zuellig Pharma Ltd., Gal{\'a}pagos NV, Sun Pharmaceuticals, Samsung Bioepis Co., Ltd., Pfizer, Eli Lilly and Company, Novartis, Galderma, Dermavant, UCB, Mylan, Bristol‐Myers Squibb, and Janssen Pharmaceuticals. Dr. DMS has received honoraria from Novozymes and Leo Pharma. Dr. GJ has received research grants from Abbvie, Leo Foundation, Afyx, InflaRx, Janssen, Novartis, UCB, Regeneron, Sanofi, Union Therapeutics and consulting fees from Coloplast, Chemocentryx, Leopharma, Incyte, Kymera and VielaBio.",

year = "2022",

month = jul,

doi = "10.1111/jdv.18075",

language = "English",

volume = "36",

pages = "e580--e583",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "John Wiley and Sons Inc.",

number = "7",

}

TY - JOUR

T1 - Amplicon sequencing demonstrates comparable follicular mycobiomes in patients with hidradenitis suppurativa compared with healthy controls

AU - Ring, H. C.

AU - Thorsen, J.

AU - Fuursted, K.

AU - Bjarnsholt, T.

AU - Bay, L.

AU - Egeberg, A.

AU - Ingham, A. C.

AU - Vedel Nielsen, H.

AU - Frew, J. W.

AU - Saunte, D. M.L.

AU - Thomsen, S. F.

AU - Jemec, G. B.

N1 - Funding Information: Dr. Ring has received research funding from the Kgl Hofbundtmager Aage Bang Foundation and honoraria as speaker from Leo Pharma. Dr. Thorsen. None. Ms. Bay None. Prof. TB none. Dr. KF None. Ms. AI None. Dr. Frew has conducted advisory work for Janssen, Boehringer‐Ingelheim, Pfizer, Kyowa Kirin, LEO Pharma, Regeneron, Chemocentryx, Abbvie and UCB, participated in trials for Pfizer, UCB, Boehringer‐Ingelheim, Eli Lilly, CSL, Janssen and received research support from Ortho Dermatologics and Sun Pharma. Mr. HV None. Dr. Thomsen has been a speaker and/or served on advisory boards for AbbVie, Almirall, Eli Lilly, Janssen, LEO Pharma, Novartis, Pfizer, Sanofi and UCB, and has received research support from AbbVie, Janssen, LEO Pharma, Novartis, Sanofi and UCB. Dr. Egeberg has received research funding from Pfizer, Eli Lilly, Novartis, Bristol‐Myers Squibb, AbbVie, Janssen Pharmaceuticals, the Danish National Psoriasis Foundation, the Simon Spies Foundation, and the Kgl Hofbundtmager Aage Bang Foundation, and honoraria as consultant and/or speaker from AbbVie, Almirall, Leo Pharma, Zuellig Pharma Ltd., Galápagos NV, Sun Pharmaceuticals, Samsung Bioepis Co., Ltd., Pfizer, Eli Lilly and Company, Novartis, Galderma, Dermavant, UCB, Mylan, Bristol‐Myers Squibb, and Janssen Pharmaceuticals. Dr. DMS has received honoraria from Novozymes and Leo Pharma. Dr. GJ has received research grants from Abbvie, Leo Foundation, Afyx, InflaRx, Janssen, Novartis, UCB, Regeneron, Sanofi, Union Therapeutics and consulting fees from Coloplast, Chemocentryx, Leopharma, Incyte, Kymera and VielaBio.

PY - 2022/7

Y1 - 2022/7

KW - Hidradenitis Suppurativa/genetics

KW - Humans

KW - Mycobiome

UR - http://www.scopus.com/inward/record.url?scp=85126823509&partnerID=8YFLogxK

U2 - 10.1111/jdv.18075

DO - 10.1111/jdv.18075

M3 - Letter

C2 - 35285081

AN - SCOPUS:85126823509

SN - 0926-9959

VL - 36

SP - e580-e583

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

IS - 7

ER -